[144] Analog Devices, Inc. SEC Filing
Analog Devices, Inc. (ADI) submitted a Form 144 reporting a proposed sale of 10,000 shares of common stock through Fidelity Brokerage Services LLC on 09/02/2025. The filing lists an aggregate market value of $2,465,000.00 and shows 491,955,436 shares outstanding for the issuer. The securities were recorded as acquired on 09/02/2025 under an option originally granted on 03/11/2020, and payment is indicated as cash. The filer reports no securities sold in the prior three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
- Regulatory compliance: The filer provided required Rule 144 details including broker, share count, acquisition method, and representation about material information.
- Transparency: The filing discloses broker name and address, acquisition origin (option grant date), and payment method (cash).
- Insider sale disclosed: A proposed sale of 10,000 shares by an insider or affiliated person is reported, which can be viewed negatively by some investors despite small size.
Insights
TL;DR: Insider plans to sell a small block of ADI stock worth $2.465M, disclosed under Rule 144.
This Form 144 documents a proposed sale of 10,000 common shares valued at $2,465,000 via a registered broker. Relative to the issuer's reported outstanding shares (491,955,436), the position size is immaterial on a percentage basis. The filing shows the shares stem from an option granted 03/11/2020 and were recorded as acquired on the same day as the proposed sale, with cash payment indicated. From a trading-impact perspective, this disclosure fulfills regulatory transparency requirements but is unlikely to materially affect ADI's market capitalization or trading dynamics given the small size versus the float.
TL;DR: The filer complied with Rule 144 disclosure; the sale is routine and appears properly documented.
The Form 144 includes required details: broker identity and address, number of shares, aggregate value, acquisition date and nature (option granted 03/11/2020), and payment method. The signer represents no undisclosed material adverse information, and there are no reported sales in the prior three months. Governance-wise, the filing demonstrates adherence to disclosure obligations for controlled or affiliated holders seeking to sell restricted or control securities. No governance red flags or material compliance issues are evident from the provided data.